Sumitomo Dainippon Pharma to acquire 10pc stake in Roivant Sciences for USD 3 billion Medical Dialogues Bureau7 Sep 2019 3:30 AM GMTThe deal, which will open up new drug lines for Sumitomo Dainippon, will also give it the option to acquire interests in an additional six businesses,...